Sub menu

Handbook tables

Table. Recommendations for MenB vaccine for people with a specified medical condition that increases their risk of invasive meningococcal disease

Age at start of vaccine course Dose requirements for people with a specified medical condition associated with increased risk of meningococcal disease
6 weeks to 5 months 4 doses (8 weeks between doses; 4th dose at 12 months of age or 8 weeks after 3rd dose, whichever is later)
6–11 months 3 doses (8 weeks between 1st and 2nd doses; 3rd dose at 12 months of age or 8 weeks after 2nd dose, whichever is later)
≥12 months 2 doses (8 weeks between doses)
Booster doses for all ages

For people with ongoing increased risk of invasive meningococcal disease who completed the primary series at:

  • ≤6 years of age — single booster dose 3 years after completing the primary schedule
  • ≥7 years of age — single booster dose 5 years after completing the primary schedule
Related diseases
Meningococcal disease

Page history

Last updated
Last reviewed

Help us improve the Australian Immunisation Handbook

Printed content may be out of date. For up to date information, always refer to the digital version:

https://immunisationhandbook.health.gov.au/resources/tables/table-recommendations-for-menb-vaccine-for-people-with-a-specified-medical-condition-that-increases-their-risk-of-invasive-meningococcal-disease

All tables

Link copied

Link, share or bookmark directly to this section of the page.